KAI1/CD82 expression in nonsmall cell lung carcinoma is a novel, favorable prognostic factor
- 1 August 1998
- Vol. 83 (3) , 466-474
- https://doi.org/10.1002/(sici)1097-0142(19980801)83:3<466::aid-cncr15>3.0.co;2-u
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Localization of the Transmembrane 4 Superfamily (TM4SF) Member PETA-3 (CD151) in Normal Human Tissues: Comparison with CD9, CD63, and α5β1 IntegrinJournal of Histochemistry & Cytochemistry, 1997
- KAI1 , a Metastasis Suppressor Gene for Prostate Cancer on Human Chromosome 11p11.2Science, 1995
- The ins and outs of the transmembrane 4 superfamilyImmunology Today, 1994
- Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA.The Journal of Experimental Medicine, 1993
- Expression of the neuroglandular antigen and analogues in melanoma. CD9 expression appears inversely related to metastatic potential of melanomaInternational Journal of Cancer, 1993
- Identification of the motility-related protein (MRP-1), recognized by monoclonal antibody M31-15, which inhibits cell motility.The Journal of Experimental Medicine, 1991
- Novel structurally distinct family of leucocyte surface glycoproteins including CD9, CD37, CD53 and CD63FEBS Letters, 1991
- A new superfamily of lymphoid and melanoma cell proteins with extensive homology to Schistosoma mansoni antigen Sm23European Journal of Immunology, 1991
- TAPA-1, the target of an antiproliferative antibody, defines a new family of transmembrane proteins.Molecular and Cellular Biology, 1990
- The primary structure of the human leukocyte antigen CD37, a species homologue of the rat MRC OX-44 antigen.The Journal of Experimental Medicine, 1989